RUNX1 and leukemia: It has been shown by many groups, including ours, that CBFβ-SMMHC sequesters most RUNX1 to the cytoplasm, supporting a dominant-negative model for CBFβ-SMMHC–induced leukemia development (8, 19, 48, 49).